These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 14221663)

  • 21. [Immunity and tuberculosis].
    WALLGREN A
    Lotta Tuberc; 1952 Dec; 22(12):931-49. PubMed ID: 13053895
    [No Abstract]   [Full Text] [Related]  

  • 22. [CHANGES IN THE TECHNOLOGY OF BCG VACCINE PRODUCTION IN HUNGARY].
    LUGOSI L
    Gyermekgyogyaszat; 1963 Nov; 14():328-34. PubMed ID: 14097503
    [No Abstract]   [Full Text] [Related]  

  • 23. Immunization of rabbits with viable BCG and nonliving cell wall vaccines.
    Larson CL; Baker RE; Baker MB
    Am Rev Respir Dis; 1968 Dec; 98(6):944-53. PubMed ID: 4881317
    [No Abstract]   [Full Text] [Related]  

  • 24. [Findings regarding stability of fluid and lyophilized BCG cultures].
    HAAS R
    Z Hyg Infektionskr; 1955; 141(6):585-91. PubMed ID: 13300400
    [No Abstract]   [Full Text] [Related]  

  • 25. [Attempted differentiation of BCG strains of various origins and lyophilization of vaccines prepared from these strains with the aid of radioactive carbon].
    KURYLOWICZ W; KUZNETSOV A; PASQUIER JF; SITEK K
    Zh Mikrobiol Epidemiol Immunobiol; 1958 Nov; 29(11):52-62. PubMed ID: 13626101
    [No Abstract]   [Full Text] [Related]  

  • 26. [TRANSFER OF IMMUNITY TO TUBERCULOSIS BY MEANS OF CELLS FROM BCG VACCINATED MICE. 1. ON THE EFFECT OF TRANSFERRED CELLS IN 2 MOUSE STRAINS DIFFERING IN SUSCEPTIBILITY TO TUBERCULOSIS].
    ASABA G; NAGATOMI H; WATABIKI S; FUKAZAWA Y; AKIYAMA T; MAEDA K
    Kekkaku; 1964 Feb; 39():55-9. PubMed ID: 14136875
    [No Abstract]   [Full Text] [Related]  

  • 27. [Current data on antituberculous immunity and on BCG vaccination].
    SAENZ A
    Sem Hop Ther Paris; 1962 Oct; 38():713-21. PubMed ID: 13976010
    [No Abstract]   [Full Text] [Related]  

  • 28. EXPERIMENTAL STUDIES ON THE IMMUNIZING POTENCY OF BCG VACCINES WITH LOW AND HIGH COUNTS OF VIABLE BACILLI.
    PRZYBYLKIEWICZ Z; MAZUR W; RYBARSKA I; BIELANSKA A
    Arch Immunol Ther Exp (Warsz); 1964; 12():173-81. PubMed ID: 14166657
    [No Abstract]   [Full Text] [Related]  

  • 29. [RELATIONS BETWEEN VOLUME OF VACCINIC FOCI AND TUBERCULIN SENSITIVITY IN SUBJECTS TREATED WITH FRESH BCG AND WITH LYOPHILIZED BCG].
    GALZERANO G; BISCIONE C; MARCATILI S
    Arch Tisiol Mal Appar Respir; 1964 Jun; 19():478-92. PubMed ID: 14203789
    [No Abstract]   [Full Text] [Related]  

  • 30. VACCINATION AGAINST TUBERCULOSIS WITH KILLED TUBERCLE BACILLI.
    SWEDBERG B
    Acta Tuberc Pneumol Scand Suppl; 1964; 58():SUPPL 58:67-76. PubMed ID: 14164138
    [No Abstract]   [Full Text] [Related]  

  • 31. [EFFECT OF LARGE DOSES OF CAFFEINE ON THE FORMATION OF IMMUNITY TO TUBERCULOSIS IN VACCINATED WHITE MICE].
    PERELMAN AE
    Biull Eksp Biol Med; 1964 Sep; 58():102-6. PubMed ID: 14273444
    [No Abstract]   [Full Text] [Related]  

  • 32. Duration of immunity to tuberculosis in mice vaccinated intravenously with oil-treated cell walls of Mycobacterium bovis strain BCG.
    Anacker RL; Barclay WR; Brehmer W; Larson CL; Ribi E
    J Immunol; 1967 Jun; 98(6):1265-73. PubMed ID: 6026748
    [No Abstract]   [Full Text] [Related]  

  • 33. EXPERIMENTAL studies of vaccination, allergy, and immunity in tuberculosis. VI. Comparative effects of BCG, H37Ra, Mycobacterium phlei and a wax-protein fraction of human tubercle bacilli.
    Am J Hyg; 1955 Nov; 62(3):270-82. PubMed ID: 13268417
    [No Abstract]   [Full Text] [Related]  

  • 34. [COMPARATIVE STUDY OF THE PROTECTIVE POWER OF ORAL BCG IN WHITE AND BROWN MICE].
    LOPES EA; FERREIRA OT
    Hospital (Rio J); 1963 Nov; 64():1075-85. PubMed ID: 14126184
    [No Abstract]   [Full Text] [Related]  

  • 35. [Utilization of radiocarbon-labeled bovine and human tubercle bacilli for the comparative study of the efficacy of freeze-dried BCG vaccines of different origins, injected by different routes].
    PASQUIER JF; KURYLOWICZ W
    C R Seances Soc Biol Fil; 1956; 150(2):281-4. PubMed ID: 13343653
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunity to tuberculosis in infancy; with special reference to vaccination in the newborn.
    GAISFORD W; GRIFFITHS M
    Tubercle; 1954 Jan; 35(1):7-14. PubMed ID: 13122769
    [No Abstract]   [Full Text] [Related]  

  • 37. [Antituberculous vaccination with freeze dried BCG vaccine. I. Properties of the dry BCG vaccine].
    KURYLOWICZ W
    Gruzlica (1926); 1955 Jan; 23(1):1-11. PubMed ID: 13251577
    [No Abstract]   [Full Text] [Related]  

  • 38. EXPERIMENTAL studies of vaccination, allergy and immunity in tuberculosis. IV. Comparison of effects of BCG and H37Ra vaccines.
    Am J Hyg; 1955 Sep; 62(2):168-84. PubMed ID: 13258564
    [No Abstract]   [Full Text] [Related]  

  • 39. [Histo-immunological dynamics of local lymphoreticular and mesenchymal tissue in BCG vaccination and in experimental tuberculosis reinfection].
    LENZINI L; BARNABE R; SBRAGIA S
    Gazz Int Med Chir; 1963 Mar; 67():481-521. PubMed ID: 13929680
    [No Abstract]   [Full Text] [Related]  

  • 40. [PASSIVE TRANSFER OF IMMUNITY TO TUBERCULOSIS BY MEANS OF CELLS FROM BCG VACCINATED MICE. II. EFFECTS OF VARIOUS PRETREATMENTS OF CELLS TO BE TRANSFERRED].
    ASABA G; NAGATOMI H; WATABIKI S; HUKAZAWA Y; AKIYAMA T; MAEDA K; USHIBA D
    Kekkaku; 1964 Apr; 39():95-9. PubMed ID: 14156231
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.